Get the Stockscreener App
20.29
1.14%
-0.308
Septerna Inc stock is traded at $20.29, with a volume of 32,844.
It is down -1.14% in the last 24 hours and down -1.52% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$20.60
Open:
$20.42
24h Volume:
32,844
Relative Volume:
0.12
Market Cap:
$907.31M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.97%
1M Performance:
-1.52%
6M Performance:
+172.26%
1Y Performance:
-6.54%
1-Day Range:
$20.15
$20.71
1-Week Range:
$20.03
$22.66
52-Week Range:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
20.35 | 918.45M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.44 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.71 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.88 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
Septerna to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph
Septerna (NASDAQ: SEPN) to join Nov. 10 & 12 Guggenheim and TD Cowen fireside chats - Stock Titan
Pattern recognition hints at Septerna Inc. upside2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Trend analysis for Septerna Inc. this weekMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Septerna Inc. stock ready for a breakoutEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
Is Septerna Inc. stock bottoming outMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Is Septerna Inc. stock a safe haven assetJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - newser.com
How sentiment analysis helps forecast Septerna Inc.2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
Regression analysis insights on Septerna Inc. performanceJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Can technical indicators confirm Septerna Inc.’s reversalEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Live market analysis of Septerna Inc.Weekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com
Using data filters to optimize entry into Septerna Inc.July 2025 Breakouts & Real-Time Market Trend Scan - newser.com
Is Septerna Inc. stock a dividend growth opportunityQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Is Septerna Inc. still worth holding after the dipWeekly Stock Report & Fast Moving Trade Plans - newser.com
Price action breakdown for Septerna Inc.Dollar Strength & Risk Managed Investment Strategies - newser.com
Statistical indicators supporting Septerna Inc.’s strength2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
Is Septerna Inc. stock a defensive play in 2025July 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Septerna Inc. stock trend outlook and recovery pathJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
How analysts rate Septerna Inc. stock todayJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
Combining price and volume data for Septerna Inc.2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
What analysts say about Septerna Inc stockStochastic Oscillator Alerts & Exceptional Return Capital - earlytimes.in
Septerna, Inc. (NASDAQ:SEPN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How to recover losses in Septerna Inc. stockJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - newser.com
Can Septerna Inc. stock resist market sell offsJuly 2025 Summary & Daily Price Action Insights - newser.com
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):